Epilepsy and Seizure Disorders
Clinical research is centered on focal epilepsy, including adult focal (partial onset) epilepsy and focal-onset seizures, with additional attention to primary generalized tonic-clonic seizures.
- Focal-onset seizures
- Adult focal epilepsy
- Primary generalized tonic-clonic seizures
These studies reflect sustained interest in seizure reduction and symptom control across multiple forms of epilepsy.
Major Depressive Disorder
The sponsor also funds research in major depressive disorder, focusing on treatment options for depressive symptoms and overall mood improvement.
- Major depressive disorder
- Depressive symptoms
This area extends the company’s interest in central nervous system conditions beyond seizure-related disease.
Bipolar Depression
Another active therapeutic area is bipolar depression, including depressive episodes associated with bipolar I or II disorder.
- Bipolar I disorder
- Bipolar II disorder
- Depressive episodes
Research in this domain addresses mood disorder management within the broader spectrum of affective disorders.
Neurology and Central Nervous System Therapeutics
The overall pipeline is strongly oriented toward neurology, with overlapping programs in seizure control and mood disorders that fall within central nervous system therapeutics.
- Neurology
- Central nervous system disorders
- Seizure control
- Mood disorders
Research activity spans multiple countries and sites, supporting development efforts in both epilepsy and psychiatric indications.
